Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–20 of 21 trials
Active filters
Clinical trials found
Published and searchable clinical trials
Searching for clinical trials...
NCT07671924
- Conditions
- Chronic Cough, Cough, Pathological Conditions, Signs and Symptoms, +5 more
- Locations
-
- BLC Clinical Research Burlington, Canada
- Diex Recherche - Quebec Québec, Canada
- Clinique Specialisee En Allergie De La Capitale Québec, Canada
- Centre D'Investigation Clinique Mauricie Inc (CIC Mauricie) Trois-Rivières, Canada
NCT07650084
- Conditions
- Chronic Cough, Cough, Pathological Conditions, Signs and Symptoms, +5 more
- Locations
-
- GSK Investigational Site Leshan, Sichuan, China
- GSK Investigational Site Beijing, China
- GSK Investigational Site Changsha, China
- GSK Investigational Site Chengdu, China
Recruiting
Efficacy of Two Doses of Duloxetine and Amitriptyline in Subjects With Refractory Chronic Cough
NCT05110144
- Conditions
- Asthma, Bronchial Diseases, Chronic Cough, +20 more
- Locations
-
- Mayo Clinic in Rochester Rochester, Minnesota, United States
NCT07070895
- Conditions
- Chronic Cough, Cough, Cough Hypersensitivity, +7 more
- Locations
-
- Hyfe Inc. Wilmington, Delaware, United States
NCT06706765
- Conditions
- Chronic Cough, Cough, Pathological Conditions, Signs and Symptoms, +5 more
- Locations
-
- University of Montana Missoula, Montana, United States
Not Yet Recruiting
Mechanisms of Change in Behavioral Cough Suppression Therapy for Refractory Chronic Cough
NCT06960759
- Conditions
- Chronic Cough, Chronic Cough (CC), Cough, +8 more
- Locations
-
- University of Colorado Anschutz Medical Campus Aurora, Colorado, United States
- Emory University Atlanta, Georgia, United States
- University of Montana Missoula, Montana, United States
Not Yet Recruiting
A Phase 2 Study of HW091077 in Participants With Refractory Chronic Cough Or Unexplained Chronic Cough (RCC/UCC).
NCT07483489
- Conditions
- Chronic Cough, Cough, Pathological Conditions, Signs and Symptoms, +5 more
- Locations
-
Not specified
Not Yet Recruiting
A 2x2 Factorial, Randomized, Open-label Trial to Evaluate Neuromodulators and Cough Control Therapy in Patients With Refractory or Unexplained Chronic Cough
NCT07288528
- Conditions
- Chronic Cough, Cough, Cough Hypersensitivity Syndrome, +8 more
- Locations
-
- Respiratory Clinical Trials Centre, University of Calgary Calgary, Alberta, Canada
- Respiratory Research Lab, McMaster University Hamilton, Ontario, Canada
- St Joseph's Health Care London London, Ontario, Canada
- Institut universitaire de cardiologie et de pneumologie de Quebec - University Laval Québec, Quebec, Canada
Completed
A 52-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough
NCT05599191
- Conditions
- Chronic Cough, Cough, Pathological Conditions, Signs and Symptoms, +5 more
- Locations
-
- GSK Investigational Site Jasper, Alabama, United States
- GSK Investigational Site Litchfield Park, Arizona, United States
- GSK Investigational Site Scottsdale, Arizona, United States
- GSK Investigational Site Little Rock, Arkansas, United States
NCT05962151
- Conditions
- Chronic Cough, Cough, Pathological Conditions, Signs and Symptoms, +5 more
- Locations
-
- McMaster University Medical Centre Hamilton, Ontario, Canada
- Inspiration Research Toronto, Ontario, Canada
- CIC Mauricie Inc. Trois-Rivières, Quebec, Canada
- Hull and East Yorkshire Hospitals NHS Trust - Castle Hill Hospital Cottingham, East Riding Of Yorkshire, United Kingdom
Completed
A Study to Assess the Efficacy and Tolerance of HRS-2261 in Subjects With Refractory Chronic Cough
NCT05733533
- Conditions
- Chronic Cough, Cough, Pathological Conditions, Signs and Symptoms, +5 more
- Locations
-
- The First Affiliated Hospital of Guangzhou Medical University Guangzhou, Guangdong, China
- Conditions
- Chronic Cough, Cough, Pathological Conditions, Signs and Symptoms, +5 more
- Locations
-
- Celerion Phoenix, Arizona, United States
- Clinical Site Partners Leesburg, Florida, United States
- Clinical Site Partners Winter Park, Florida, United States
NCT04678206
- Conditions
- Chronic Cough, Cough, Pathological Conditions, Signs and Symptoms, +5 more
- Locations
-
- Phoenix Medical Research Inc Peoria, Arizona, United States
- Little Rock Allergy and Asthma Clinical Research Center Little Rock, Arkansas, United States
- Southern California Institute For Respiratory Diseases, Inc Los Angeles, California, United States
- Allergy and Asthma Associates of Southern California Mission Viejo, California, United States
NCT03282591
- Conditions
- Chronic Cough, Cough, Pathological Conditions, Signs and Symptoms, +5 more
- Locations
-
- Study Site 130 Los Angeles, California, United States
- Study Site 128 Mission Viejo, California, United States
- Study Site 123 San Diego, California, United States
- Study Site 127 San Jose, California, United States
NCT02397460
- Conditions
- Chronic Cough, Cough, Pathological Conditions, Signs and Symptoms, +5 more
- Locations
-
- The Medicines Evaluation Unit Manchester, United Kingdom
Completed
A Dose Escalation Study of Gefapixant (AF-219/MK-7264) in Refractory Chronic Cough (MK-7264-010)
NCT02349425
- Conditions
- Chronic Cough, Cough, Pathological Conditions, Signs and Symptoms, +5 more
- Locations
-
Not specified
NCT02612610
- Conditions
- Chronic Cough, Cough, Pathological Conditions, Signs and Symptoms, +5 more
- Locations
-
Not specified
NCT02612623
- Conditions
- Chronic Cough, Cough, Pathological Conditions, Signs and Symptoms, +5 more
- Locations
-
- Afferent Investigative Site Mission Viejo, California, United States
- Afferent Investigative Site San Jose, California, United States
- Afferent Investigative Site Colorado Springs, Colorado, United States
- Afferent Investigative Site Largo, Florida, United States
NCT02476890
- Conditions
- Chronic Cough, Cough, Pathological Conditions, Signs and Symptoms, +5 more
- Locations
-
Not specified
NCT02412020
- Conditions
- Chronic Cough, Cough, Pathological Conditions, Signs and Symptoms, +5 more
- Locations
-
- Erasmus Medical Center Rotterdam, Netherlands
- Isala Zwolle, Netherlands
- Hull Clinical Trials Unit Cottingham, East Yorkshire, United Kingdom
- Uni Hospital Leicester Leicester, United Kingdom